Page last updated: 2024-08-18

pyrroles and Dermatomyositis

pyrroles has been researched along with Dermatomyositis in 17 studies

Research

Studies (17)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (5.88)	29.6817
2010's	11 (64.71)	24.3611
2020's	5 (29.41)	2.80

Authors

Authors	Studies
Albayda, J; Castillo, R	1
Eason, C; Elston, D; Plante, J; Robinson, I; Santa Lucia, G	1
Allenbach, Y; Benveniste, O; Landon-Cardinal, O	1
Almeida de Jesus, A; Carrasco, R; Goldbach-Mansky, R; Hwang, S; Jung, L; Kim, H; Kuehn, HS; Rider, LG; Rosenzweig, S; Sabbagh, S	1
Jiménez-Gallo, D; Linares-Barrios, M; Navarro-Navarro, I; Rodríguez-Hernández, C; Rodríguez-Mateos, ME	1
Fujiwara, M; Ishikawa, Y; Kasuya, T; Kita, Y	1
Crespo Cruz, A; Del Boz, J; Romero Gómez, C	1
Arai, S; Arima, M; Kurasawa, K; Maezawa, R; Namiki, Y; Owada, T; Takamura, Y; Tanaka, A	1
Aggarwal, R; Charlton, D; Moghadam-Kia, S; Oddis, CV	1
Agarwal, P; Frye, BC; May, AM; Rizzi, M; Thiel, J; Venhoff, N; Voll, RE; Wendel, S	1
Chen, Z; Wang, X; Ye, S	1
Komai, E; Takemoto, M; Yokote, K	1
Femia, AN; Kurtzman, DJ; Lin, J; Merola, JF; Patel, M; Vleugels, RA; Wright, NA	1
Christopher-Stine, L; Paik, JJ	1
Hydzik, P; Szpak, D	1
Cannon, CS	1
Cerottini, JP; Noël, B; Panizzon, RG	1

Trials

1 trial(s) available for pyrroles and Dermatomyositis

Article	Year
Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease. The New England journal of medicine, 2019, 07-18, Volume: 381, Issue:3 Topics: Adult; Autoantibodies; Dermatomyositis; Drug Therapy, Combination; Female; Glucocorticoids; Historically Controlled Study; Humans; Interferon-Induced Helicase, IFIH1; Janus Kinase Inhibitors; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Piperidines; Pyrimidines; Pyrroles	2019

Article

Year

Tofacitinib in Amyopathic Dermatomyositis-Associated Interstitial Lung Disease.

The New England journal of medicine, 2019, 07-18, Volume: 381, Issue:3

Topics: Adult; Autoantibodies; Dermatomyositis; Drug Therapy, Combination; Female; Glucocorticoids; Historically Controlled Study; Humans; Interferon-Induced Helicase, IFIH1; Janus Kinase Inhibitors; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Piperidines; Pyrimidines; Pyrroles

2019

Other Studies

16 other study(ies) available for pyrroles and Dermatomyositis

Article	Year
Refractory alopecia universalis associated with dermatomyositis successfully treated with tofacitinib. Modern rheumatology case reports, 2022, 06-24, Volume: 6, Issue:2 Topics: Adult; Alopecia; Alopecia Areata; Dermatomyositis; Female; Humans; Interferons; Piperidines; Pyrimidines; Pyrroles	2022
A Retrospective Review of Tofacitinib in the Treatment of Refractory Dermatomyositis. Journal of drugs in dermatology : JDD, 2022, Oct-01, Volume: 21, Issue:10 Topics: Dermatomyositis; Humans; Immunologic Factors; Piperidines; Pyrimidines; Pyrroles; Retrospective Studies; Treatment Outcome	2022
Reply: Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib. Brain : a journal of neurology, 2019, 11-01, Volume: 142, Issue:11 Topics: Autoantibodies; Dermatomyositis; Humans; Piperidines; Pyrimidines; Pyrroles	2019
Treatment of anti-MDA5 autoantibody-positive juvenile dermatomyositis using tofacitinib. Brain : a journal of neurology, 2019, 11-01, Volume: 142, Issue:11 Topics: Autoantibodies; Dermatomyositis; Humans; Interferon Type I; Piperidines; Pyrimidines; Pyrroles	2019
Treatment of refractory anti-NXP2 and anti-TIF1γ dermatomyositis with tofacitinib. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2021, Volume: 19, Issue:3 Topics: Autoantibodies; Dermatomyositis; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Tofacitinib for recurrence of antimelanoma differentiation-associated gene 5 antibody-positive clinically amyopathic dermatomyositis after remission: A case report. Medicine, 2020, Sep-11, Volume: 99, Issue:37 Topics: Autoantibodies; Dermatomyositis; Female; Humans; Interferon-Induced Helicase, IFIH1; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Recurrence	2020
Good Response to Tofacitinib in Refractory Amyopathic Dermatomyositis. Actas dermo-sifiliograficas, 2021, Volume: 112, Issue:4 Topics: Dermatomyositis; Humans; Piperidines; Pyrimidines; Pyrroles	2021
Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis. Rheumatology (Oxford, England), 2018, 12-01, Volume: 57, Issue:12 Topics: Adult; Aged; Dermatomyositis; Drug Therapy, Combination; Female; Ferritins; Glucocorticoids; Humans; Interferon-Induced Helicase, IFIH1; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Piperidines; Prognosis; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Survival Rate; Treatment Outcome	2018
Management of refractory cutaneous dermatomyositis: potential role of Janus kinase inhibition with tofacitinib. Rheumatology (Oxford, England), 2019, 06-01, Volume: 58, Issue:6 Topics: Adult; Aged; Dermatomyositis; Female; Humans; Immunosuppressive Agents; Janus Kinase Inhibitors; Male; Middle Aged; Piperidines; Pyrimidines; Pyrroles; Retreatment; Treatment Outcome	2019
Successful treatment of extensive calcifications and acute pulmonary involvement in dermatomyositis with the Janus-Kinase inhibitor tofacitinib - A report of two cases. Journal of autoimmunity, 2019, Volume: 100 Topics: Calcinosis; Dermatomyositis; Female; Humans; Lung Diseases, Interstitial; MAP Kinase Kinase 4; Middle Aged; Piperidines; Pyrimidines; Pyrroles	2019
Atorvastatin-induced dermatomyositis in a 47-year-old woman with Sjögren's syndrome. Acta cardiologica, 2015, Volume: 70, Issue:3 Topics: Anticholesteremic Agents; Atorvastatin; Dermatomyositis; Female; Heptanoic Acids; Humans; Hyperlipidemias; Middle Aged; Pyrroles; Sjogren's Syndrome	2015
Tofacitinib Citrate for Refractory Cutaneous Dermatomyositis: An Alternative Treatment. JAMA dermatology, 2016, 08-01, Volume: 152, Issue:8 Topics: Administration, Oral; Adult; Dermatomyositis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Middle Aged; Piperidines; Protein Kinase Inhibitors; Pyrimidines; Pyrroles; Sampling Studies; Severity of Illness Index; Treatment Outcome	2016
A case of refractory dermatomyositis responsive to tofacitinib. Seminars in arthritis and rheumatism, 2017, Volume: 46, Issue:4 Topics: Azathioprine; Dermatomyositis; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methotrexate; Middle Aged; Mycophenolic Acid; Piperidines; Pyrimidines; Pyrroles; Retreatment; Treatment Failure; Treatment Outcome	2017
[Side effects of the HMG-CoA reductase inhibitors (statins). Lupus erythematosus induced by Atorvastatin therapy]. Przeglad lekarski, 2011, Volume: 68, Issue:8 Topics: Anticholesteremic Agents; Arthralgia; Atorvastatin; Autoantibodies; Collagen Diseases; Creatine Kinase; Dermatomyositis; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Middle Aged; Pyrroles; Transaminases	2011
Statin-induced rhabdomyolysis and dermatomyositis: a rare combination. JAAPA : official journal of the American Academy of Physician Assistants, 2012, Volume: 25, Issue:8 Topics: Atorvastatin; Comorbidity; Dermatomyositis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrroles; Rhabdomyolysis	2012
Atorvastatin-induced dermatomyositis. The American journal of medicine, 2001, Jun-01, Volume: 110, Issue:8 Topics: Adult; Antibodies, Antinuclear; Apoptosis; Atorvastatin; Creatine Kinase; Dermatomyositis; Heptanoic Acids; Humans; Hydroxymethylglutaryl CoA Reductases; Keratinocytes; Male; Pyrroles	2001